![Nir Arbel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nir Arbel is the founder of Carmentix Pte Ltd. Formerly, Chief Product Officer at Evogene Ltd. from 2021 to 2024.
Education includes a doctorate from Ben-Gurion University of the Negev.
| Unternehmen | Position | Ende |
|---|---|---|
| EVOGENE LTD. | Corporate Officer/Principal | 01.09.2024 |
Carmentix Pte Ltd.
 Carmentix Pte Ltd. Packaged SoftwareTechnology Services Develops novel biomarker prognostic panels for pre term birth | Vorstandsvorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 3 |
|---|---|
Ben-Gurion University of the Negev
 Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evogene Ltd.
 Evogene Ltd. BiotechnologyHealth Technology Operates as computational biology company, which focuses on product discovery and development | Health Technology |
Carmentix Pte Ltd.
Carmentix Pte Ltd. Packaged SoftwareTechnology Services Develops novel biomarker prognostic panels for pre term birth | Technology Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
